Vertex Pharma (VRTX) Enters Amended Research Collaboration with CFFT; Provides for Upfront Program Award
Tweet Send to a Friend
Vertex Pharma (NASDAQ: VRTX) disclosed the following in a U.S. SEC filing on Friday:Item 8.01 Other EventsOn October 13, 2016 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
